Objectives: This study was a detailed investigation of Staphylococcus epidermidis clinical isolates exhibiting linezolid resistance.
Introduction
Linezolid is the first and only antibiotic agent of the oxazolidinone class that is approved for the treatment of infections caused by a variety of Gram-positive pathogens. More importantly, it is used as an agent of last resort for the treatment of complicated soft tissue infections and pneumonia caused by MDR strains. Oxazolidinones disrupt bacterial protein synthesis by binding to the peptidyl transferase centre of the ribosome, thereby inhibiting transition of the aminoacyl-tRNA to the A site. 1 Linezolid resistance is mediated by different mechanisms: (i) acquisition of the plasmid-borne cfr gene, which encodes a ribosomal methyltransferase; (ii) mutations in the linezolid 23S rRNA binding site; or (iii) mutations in genes encoding the 50S ribosomal proteins L3, L4 and L22 of the peptide translocation centre of the ribosome. 2 -6 After introduction of this oxazolidinone for clinical use in 2000, resistance to linezolid rarely occurred and was exclusively based on target site mutations in the 23S rRNA. 4, 5 To date, clinical isolates most commonly exhibit base-pair substitutions G2576T and T2500A; however, a variety of other 23S rRNA mutations that may account for linezolid resistance have been reported. 6 Another, less common, linezolid resistance mechanism involves mutations in the 50S ribosomal proteins L3, L4 and L22. 5 -7 Some of these mutations are located close to the peptidyl transferase centre of the ribosome. Thus, changes in amino acid composition are speculated to impair linezolid binding, hence resulting in increased antibiotic resistance. 5 The first clinical linezolid-resistant MRSA with an acquired cfr gene was reported from Colombia in 2007 2 ; however, cfr was detected earlier in Staphylococcus spp. of animal origin, in 1997. 8 The cfr gene encodes a methyltransferase that specifically targets the adenine nucleotide of the 23S rRNA at position 2503 (A2503). Modification of A2503 results in a phenotype commonly referred to as PhLOPS A , and confers resistance to at least five antimicrobial classes (phenicols, lincosamides, oxazolidinones, pleuromutilins and streptogramin A antibiotics). 9 Until now, cfr-positive staphylococci from human clinical isolates have rarely been detected in Germany; however, the emergence and outbreaks of these strains have been reported from other countries worldwide. 10 -13 While mutation-dependent resistance to linezolid is due to the successive accumulation of chromosomal base-pair substitutions, acquisition of the methyltransferase gene is mediated by horizontal gene transfer of the respective cfr-encoding mobile genetic element. Both chromosomal integration and plasmid location have been reported for the cfr locus. 8, 14 According to a review by Shen et al., 15 cfr-flanking regions are likely to encode transposases and mobilization proteins of certain insertion elements, such as IS21-558 and IS256-like sequences. This highlights the potential of the resistance locus to be mobilized and exchanged among the bacterial community. Besides transposon-mediated dissemination, several variants of cfr plasmids have been described in a vast number of staphylococcal species. They were reported to differ substantially in size, ranging from 7.1 to 45 kb. 16 Moreover, plasmids of the same subtypes, e.g. pSCFS3 and derivatives, have been isolated from different animal hosts and staphylococcal species, such as Staphylococcus lentus and Staphylococcus aureus, emphasizing the possibility of inter-species transfer. 17 Furthermore, cfr-carrying vectors are not limited to staphylococci, but are rather distributed across the phylum of Gram-positive bacteria, including bacilli and enterococci, and have been shown to propagate even in Gram-negative Escherichia spp. 18 -20 Here, we report the detailed investigation of 36 Staphylococcus epidermidis clinical isolates from German hospitals exhibiting linezolid resistance. Six of these strains additionally harboured a plasmid-encoded cfr gene. Examination of the plasmids by nextgeneration sequencing technology revealed the incorporation of cfr into a conjugative plasmid of the pGO1 type or a pSK73-like backbone. As identical vectors were obtained from isolates of different genetic backgrounds, the presence of cfr in these strains clearly indicates a certain degree of plasmid dissemination within hospital environments.
Materials and methods

Strain collection
We identified 36 S. epidermidis strains exhibiting linezolid resistance between January 2012 and April 2013. The strains originated from eight different German hospitals (A -H) and were sent to the National Reference Centre for Staphylococci and Enterococci for resistance determination and further molecular characterization. The majority of these strains were derived from bloodstream infections, wound infections and catheter-associated infections on surgical wards and ICUs (Table S1 , available as Supplementary data at JAC Online). We received consecutive isolates over a 1 year period from hospitals A and D; in these cases spreading of a single clone within the wards was suspected.
Antimicrobial susceptibility testing
The antimicrobial susceptibility of the isolates was determined by using the broth microdilution method according to DIN58940 and applying EUCAST breakpoints for interpretation of the results (www.eucast.org); the Etest w for linezolid was used to confirm preliminary results. The following antibiotics were tested: penicillin, oxacillin, cefoxitin, fosfomycin, gentamicin, linezolid, erythromycin, clindamycin, tetracycline, tigecycline, vancomycin, teicoplanin, ciprofloxacin, mupirocin, moxifloxacin, daptomycin, fusidic acid, rifampicin and trimethoprim/sulfamethoxazole. Transformed S. aureus RN4220 were analysed for susceptibility to linezolid and florfenicol (according to the CLSI document M31-A3, 2008).
DNA extraction
Strains were grown overnight in tryptic soy broth at 378C. DNA was extracted using the DNeasy tissue kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions with the modification that lysostaphin (100 mg/L; Sigma, Munich, Germany) was added to the cell lysis step.
Detection of the cfr gene and analysis of ribosomal target site mutations
Isolates were screened for the presence of the cfr gene by PCR as described previously. 17 To analyse possible linezolid resistance-mediating mutations, the rplC, rplD, rplV genes and partial sequences of the 23S rRNA were amplified by PCR. 3, 4 The respective amplicons were sequenced on both strands and the software package DNASTAR Lasergene was used to analyse the nucleotide and derived amino acid sequences that were obtained. Results were compared with those from linezolid-susceptible clinical S. epidermidis strains (11-03671, 11-01450) and the S. epidermidis reference strain ATCC 12228.
Molecular typing
SmaI macrorestriction analysis was performed according to the HARMONY protocol. 21 Cluster analysis was performed with the BioNumerics software package (Applied Maths, Sint-Martens-Latem, Belgium), using the Dice coefficient, and visualized as a dendrogram by the UPGMA (unweighted pair group method with arithmetic mean) algorithm with 1% tolerance and 1% optimization settings. A similarity cut-off of 90% was used to define clusters, which were designated by roman numbers. MLST for S. epidermidis was carried out as published in 2007. 22 The presence of the icaA gene was verified as described elsewhere. 23 
Transformation of cfr-carrying plasmids
Total plasmids of the cfr-positive S. epidermidis isolates were extracted using a plasmid extraction kit according to the manufacturer's instructions (Qiagen, Hilden, Germany). Protoplasts of laboratory strain S. aureus RN4220 were isolated as described elsewhere, 24 transformed with the respective cfr plasmids and spread on regeneration plates prior to selection on brain heart infusion agar plates supplemented with 10 mg/L florfenicol (Sigma).
Plasmid sequencing and bioinformatical analyses
A total of 1 ng of plasmid DNA was used for library generation using the Nextera XT DNA Sample Prep Kit according to the manufacturer's recommendations (Illumina). Sequencing was carried out on a MiSeq instrument and performed in paired-end mode using a v2 chemistry-based cartridge 500 on a 14 tile flow cell (500-Cycle Reagent Kit, Illumina). Mapping of the obtained reads to published cfr-carrying plasmids, such as pSEPI8573, was carried out using a BWA-SW-based pipeline developed inhouse. Furthermore, de novo assembly of the vectors p12-02179 and p12-02300 was performed by using the open source assembler-pipeline SPAdes 2.5.0 (http://bioinf.spbau.ru/spades). Subsequently, ABACAS was Linezolid resistance in Staphylococcus epidermidis 1631 JAC implemented to deplete contigs of chromosomal origin. To this end, the genome of S. aureus NCTC 8325 was chosen as 'filter' DNA. S. aureus RN4220, which served as a host for plasmid propagation and isolation, was derived from NCTC 8325 by UV radiation, chemical mutagenesis and deletion of prophages. 25 Dismissing all contigs that aligned with the S. aureus NCTC 8325 genome drastically reduced the number of remaining contigs, which were aligned thereafter by using the Geneious software to generate a single consensus sequence. The closed-circle conformation of the plasmids was verified experimentally by PCR and Sanger sequencing using oligonucleotides p12-02179_cc_fw (5
, respectively. Cycling conditions were as follows: one cycle of 958C for 120 s, followed by 30 cycles of 958C for 30 s, 558C for 30 s and 728C for 2 min, before final extension at 728C for 7 min.
Annotation of the plasmid sequence was performed by the RAST server (version 4.0, http://rast.nmpdr.org/) and manually modified after coding DNA sequence comparison with homologous plasmids. Plasmids p12-00322 and p12-02178 were generated by mapping of MiSeq reads to the final reference sequence of p12-02179 using the Geneious mapping algorithm. Likewise, p12-01631 and p12-01787 were constructed by mapping to the generated sequence of plasmid p12-02300. Plasmids were grouped into two categories, C1 and C2, according to their backbone sequence. As representatives of each category, nucleotide sequences of p12-00322 [plasmid category 1 (C1)] and p12-02300 [plasmid category 2 (C2)] were deposited in the GenBank database under the following accession numbers: KM521836 (p12-00322) and KM521837 (p12-02300).
Filter-mating experiments
Transfer capabilities of plasmid p12-00322 were analysed by filter-mating experiments with a linezolid-susceptible S. epidermidis strain as a recipient. To discriminate the recipient from the donor strain, a rifampicin/fusidic acid-resistant S. epidermidis 13-02152 was generated in a two-step process. Likewise, Enterococcus faecalis OG1RF served as recipient bacteria. Putative transconjugants of filter-mating experiments were selected on agar plates containing 10 mg/L florfenicol, 30 mg/L rifampicin and 20 mg/L fusidic acid. Furthermore, transconjugants were routinely screened for acquisition of the cfr gene/plasmid by PCR and further by determining susceptibility to the chloramphenicol derivative florfenicol.
Results
Description of isolates and results of molecular typing
According to their macrorestriction patterns, the 36 S. epidermidis isolates were clustered into five PFGE types (Table 1) . MLST revealed the following sequence types: ST2, ST5, ST22 and ST23. The icaA gene was present in all isolates, except the four ST5 isolates. Six strains harboured the cfr gene for RNA methyltransferase. Three of these isolates (12-00322, 12-02178, 12-02179) originated from patients in hospital C and showed a different genetic background (ST2, ST22, ST23). The other three cfr-positive strains were obtained from patients in hospitals A (12-01787, 12-02300) and G (12-01631). The strains from hospital A were the only two cfr-positive isolates among the 10 S. epidermidis isolates (all of them showing an identical genetic background of ST 2/PFGE type IV) collected over a 1 year period as part of a suspected outbreak.
Antimicrobial susceptibility and putative resistance mechanisms
The isolates showed decreased susceptibility to linezolid, exhibiting MICs in the range of 8 to .256 mg/L (Table 1) . Furthermore, they Bender et al. Table 1 summarizes the results with respect to the presence of the cfr gene, mutations in the 23S rRNA and in the ribosomal proteins for each isolate and also for linezolid-susceptible control strains. Regarding the linezolid 23S rRNA binding site, the following modifications were found: C2161T, G2576T, T2502A and C2532T. Sequence chromatograms showed no evidence of nucleotide mixtures at the respective positions. Amino acid alterations in L3 comprised Leu101Val, His146Gln, Gly152Asp, Val154Leu, Ala157Arg and Asp159Tyr. The following amino acid changes were found in L4: substitutions Glu128Ala, Gln174Arg and Arg182Gln and a His138 insertion. Mutations in rplV were synonymous when detected. It is worth noting that C2161T in the 23S rRNA and Leu101Val in L3 were also found in the linezolid-susceptible isolates 11-03671 and 11-01450. Six isolates were positive for the cfr gene. No apparent correlation was observed between the occurrence of certain nucleotide mutations, the presence of cfr and the level of linezolid resistance.
Transformation of cfr-carrying plasmids into S. aureus RN4220 and determination of the cfr-mediated resistance phenotype
Due to the presence of multiple mutations in linezolid-associated genes (see above) and because expression of cfr does not necessarily mediate tolerance to oxazolidinones, 26 plasmids were extracted from the six cfr-positive S. epidermidis and transferred into the restriction-deficient strain S. aureus RN4220 by means of protoplast transformation. Acquisition of cfr was verified by colony PCR (data not shown) and cfr-mediated resistance to florfenicol, linezolid and clindamycin was determined by broth microdilution. As shown in Table 2 , introduction of the cfr-containing plasmids reconstituted resistance to all the antibiotics tested. This unequivocally demonstrates that cfr plasmids of S. epidermidis are capable of mediating resistance to the oxazolidinone linezolid, the chloramphenicol derivative florfenicol and to the lincosamide clindamycin in a susceptible S. aureus background.
Characterization of cfr-carrying plasmids by PFGE and next-generation sequencing
Electrophoretic separation of bacterial DNA after S1 nuclease treatment produced a single plasmid of 35 -40 kb for S. aureus RN4220 bacteria that had acquired one of the cfr-carrying vectors, whereas the control strain S. aureus RN4220 lacked any apparent plasmid band (not shown). In order to determine the episomal backbone into which the cfr locus was incorporated, plasmids were subjected to library generation and next-generation sequencing (Illumina), thereby producing paired-end reads 250 bp in length. The cfr-carrying plasmid pSEPI8573 from S. epidermidis 27 served as a reference for subsequent mapping approaches using a BWA-SW-based mapping pipeline developed in-house. However, the percentage of coverage varied greatly (not shown), thus suggesting a certain degree of diversity between the plasmid backbones.
De novo assembly and description of S. epidermidis cfr plasmids
To include putative neglected sequences and to resolve the myriad ambiguous sites revealed by mapping analyses, de novo assemblies were performed utilizing the open-source pipeline SPAdes 2.5.0 with default options (http://bioinf.spbau.ru/spades). This yielded plasmid p12-02179 of 36754 bp and p12-02300 of 38864 bp. According to the vector backbone, plasmids were grouped into two categories, C1 and C2 (Table 1) . Mapping of the reads for plasmids p12-00322 and p12-02178 to the newly generated p12-02179 (C1) and those for p12-01631 and p12-01787 to p12-02300 (C2) disclosed the remaining vector sequences. The closed-circle conformation of the plasmids was verified by PCR overlapping the 5 ′ -and 3 ′ -regions of the in silico-generated sequences (data not shown). The three plasmids belonging to C1 all exhibited a size of 36754 bp, whereas the total size of C2 plasmids differed slightly (maximum 190 bp). This was due to varying repetitive stretches within the respective nucleotide sequences as observed by Sanger sequencing of this particular region (not shown). DNA comparison revealed 100% identity on the nucleotide level for C1-category plasmids. Likewise, p12-01787 and p12-02300 of category C2 showed no difference in nucleotide sequences. In contrast, alignment of p12-01631 to p12-02300 (both C2) displayed minor variations, sharing 99.7% sequence identity.
Because previous mappings of C1 plasmid reads to known cfr-carrying vectors showed a very low degree of similarity, it was assumed that the cfr locus was incorporated into a different plasmid backbone. Generic annotation of plasmid sequence p12-00322 by the RAST server revealed 40 coding DNA sequences (Figure 1a) . Homology of the backbone was most prominent to plasmids such as S. aureus pV030-8. Plasmid pV030-8 is a member of the family of mupirocin resistance plasmids (accession number EU366902.1). Other homologues of comparable query coverage and identical sites include S. aureus HUNSC491 pPR9 and S. aureus pGO1 plasmids, the prototype for multiresistant, self-transferable plasmids. 28 The conjugation element (tra/trs), as well as the region containing the origin of transfer (oriT) and the associated nickase gene nes, were well conserved in p12-00322 and homologues of category C1. Also, p12-00322 encoded the master transcriptional regulator of proteins involved in plasmid segregation, artA; however, it was one amino acid short Furthermore, p12-00322 and homologues displayed an element comprising the methyltransferase-encoding cfr, located adjacent to the integrase/resolvase genes istAS and istBS and the ATP-binding protein gene lsa(B) (Figure 1a ). Detailed analyses of the locus disclosed that this region was highly similar to the transposon hybrid IS21 -558 of distantly related plasmids, such as the 43 kb plasmid pSCFS6 of Staphylococcus warneri or Bender et al.
Staphylococcus simulans. 30 Although being similar in overall composition, identical copies of IS257-like transposases, rather than IS21-elements, flanked the cfr locus in p12-00322-like plasmids.
This was in contrast to the plasmids belonging to category C2, namely p12-01631, p12-01787 and p12-02300. Figure 1(b) depicts p12-02300 as a representative of C2 plasmids with an apparent size of 38864 bps. They displayed the highest degree of similarity to staphylococcal vectors such as pSK73, with 69% of the published DNA sequence showing 99% identity. Further similarities were prominent to S. epidermidis pSEPI8573 and S. aureus pSA737, revealing 85% identity in 78% of the vector sequences. Plasmids p12-02300 and homologues harboured a truncated transposase B (tnpB) and the tnpA gene of transposon Tn558; however, Tn558 of p12-02300 was disrupted by insertion of the methyltransferase gene into tnpB (Figure 1b) . In addition, the site-specific recombinase bin3, tnpC, a putative oxidoreductase gene and the phenicol exporter gene fexA were located further downstream of the resistance locus. Expression of a functional fexA was congruent with MIC determination assays of transformed S. aureus RN4220. Hence, strains harbouring C2 vectors exhibited elevated resistance to florfenicol (MIC .128 mg/L) ( Table 2 ). Interestingly, C1 category plasmids examined in the present study did not encode the exporter fexA of the major facilitator superfamily, thus showing MICs of 128 mg/L only ( Table 2 ).
Conjugational transfer of S. epidermidis cfr plasmids
Examination of the nucleotide sequence of C1 category plasmids, such as p12-00322, revealed the presence of certain loci potentially involved in plasmid mobilization and subsequent transfer. To determine whether p12-00322 was capable of undergoing self-transfer to a related species, filter-mating experiments were conducted. Calculated transfer efficacies were in the range of 2.8×10 27 to 3.3×10
28 transconjugants per donor cell. Functionality of cfr in transconjugant strains was further verified by MIC determination assays, hence showing elevated MIC levels (.512 mg/L) upon acquisition of the cfr-containing plasmid p12-00322 (not shown). In order to determine broad host-range propagation and transmission of the novel staphylococcal cfr plasmid, we performed filtermating experiments with E. faecalis OG1RF as a recipient strain. Plasmid p12-00322 transferred from S. epidermidis 12-00322 to E. faecalis OG1RF with a frequency of 6.4×10
27 transconjugants per donor cell. As observed for the transconjugants of S. epidermidis 13-02152RF, transconjugants of E. faecalis OG1RF developed elevated MIC levels of .512 mg/L to florfenicol compared with the susceptible recipient strain (not shown).
Discussion
Molecular epidemiology of linezolid-resistant S. epidermidis
In the present study, we characterized linezolid-resistant S. epidermidis originating from eight different hospitals in Germany. Several reports describing the molecular typing of nosocomial S. epidermidis using different methodologies revealed remarkable genetic diversity within the population. Furthermore, epidemic clones seem to evolve quickly through recombination and frequent exchange of genetic mobile elements. 31, 32 Here, four different sequence types, belonging to globally distributed lineages, were identified among our 36 isolates: ST2, ST5, ST22 and ST23. According to an improved MLST scheme there are nine clonal lineages composing the nosocomial S. epidermidis population worldwide. 22, 32 Also, strains of ST2, ST5 and ST22 are clustered into CC5 (formerly known as CC2), which is the most prevalent clonal complex regarding the nosocomial S. epidermidis population. 32 Recent studies showed that strains assigned to CC5 were predominant in the community, indicating the capability of these lineages to adapt to different environments. 33 Macrorestriction analysis of genomic DNA is widely used to track the spread of single S. epidermidis clones on a local level in clinical settings. 34 -36 By using a cut-off similarity value of 90%, five PFGE types were defined among our isolates. The 12 S. epidermidis ST2 strains comprised two PFGE types (IV, V), with 10 of these strains (ST2, PFGE type IV) being isolated from hospital A over a 1 year period. The first linezolid-resistant strains in hospital A originated from different clinical divisions, which prompted environmental screening of interdisciplinary wards. This screening revealed additional linezolid-resistant S. epidermidis isolates. Besides showing the same PFGE type and sequence type, these isolates also exhibited identical ribosomal protein mutations. Therefore, transmission of this particular clone across interdisciplinary wards is quite likely. Two isolates additionally carried a cfr C2 plasmid. The acquisition of these plasmids via horizontal gene transfer during spread of the clone is possible. Similar scenarios describing the exchange of cfr plasmids within staphylococci of one hospital were published elsewhere.
11,27,37 The 19 S. epidermidis ST22 isolates were grouped in PFGE type I. Fourteen of them were consecutive isolates from hospital D, where transmission of a single clone over 1 year was suspected. In addition to ST22 and PFGE type I, these strains showed an identical pattern of ribosomal mutations; however, isolates from hospital E also exhibited those characteristics. There are no epidemiological data available concerning the spread of a single clone in hospitals B, E, F, G and H, even though there are isolates from the same hospital expressing identical characteristics (e.g. isolates from hospital F: ST5, PFGE type II; isolates from hospital E: ST22, PFGE type I). Two distinct clones (ST23, PFGE type III; ST2, PFGE type IV) were isolated from the same patient in hospital C, both of them possessing a cfr-carrying C1 plasmid. A strain isolated earlier in the same hospital that exhibited PFGE type I and ST22 also carried this plasmid. The occurrence of a C1 plasmid in three S. epidermidis strains of different genetic backgrounds, but detected in one hospital and in two distinct isolates from one patient, strongly indicates plasmid dissemination between these strains within the hospital environment.
There are several reports concerning outbreaks caused by linezolid-resistant S. epidermidis worldwide, 38 but data from Central European hospitals remain scarce. One of the latest articles describes the emergence and persistence of a linezolid-resistant ST2 clone in a Portuguese hospital for at least 7 months. 39 In addition, Mihaila et al. 40 reported a dual outbreak of bloodstream infections with linezolid-resistant S. epidermidis and Staphylococcus pettenkoferi in a liver ICU in Paris. Their analysis revealed that the patients may have acquired the linezolid-resistant CoNS through cross-infection and they concluded that the emergence of these strains was rather the result of transmission of clonal strains than the selection of resistant mutants under therapeutic treatment. In contrast, several reports describe the establishment of linezolid-resistant clones in hospitals, which was preceded by an increase in the linezolid utilization rate. 41 Likewise, the restriction
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1635 JAC of linezolid usage and infection control measures was associated with disappearance of these strains. 11 However, data concerning the usage of linezolid in the hospitals where our isolates originated are not available to us. Projects that collect data on antibiotic consumption from a limited number of German hospitals, e.g. SARI (Surveillance System of Antibiotic Use and Bacterial Resistance in Intensive Care Units), revealed an increasing consumption of last-resort antibiotics such as linezolid over the last few years. 42, 43 Thus, collecting and publishing data on antibiotic consumption is essential to identify factors that could lead to the development and spread of antibiotic-resistant bacteria.
Evaluation of linezolid resistance-determining mutations
We further examined our clinical isolates for putative linezolid resistance mechanisms. Several modifications of the 23S rRNA are known which may contribute to linezolid resistance in CoNS. These mutations comprise not only nucleotides of the peptidyl transferase centre, but also nucleotides that are more distantly located. 5, 44, 45 By subtracting mutations also present in the linezolid-susceptible control strains, our linezolid-resistant isolates mainly carried G2576T, T2502A and C2532T modifications. G2576T is the most common mutation found in clinical isolates of both Staphylococcus and Enterococcus. 38, 44 The mutation is associated with increased linezolid MICs, because significant correlation between the number of mutated rRNA operons and elevated MICs for linezolid was observed. 5 To our knowledge this is the first description of T2502A and C2532T modifications in CoNS. Whether these mutations confer linezolid resistance remains to be determined, as involvement of a variety of other, already published, 23S rRNA mutations has not been functionally proven. 46 Our linezolid-resistant isolates revealed several nonsynonymous mutations in the ribosomal protein L3, such as His146Gln, Gly152Asp, Val154Leu, Ala157Arg and Asp159Tyr substitutions. These alterations were described previously to impact linezolid susceptibility. 3, 5 We further identified changes in L4 ribosomal proteins (combination of Glu128Ala/Gln174Arg/ Arg182Gln changes and/or an His138 insertion) that have not been described to date. However, data demonstrating the association of mutations in L3 and L4 proteins with increased levels of linezolid resistance in staphylococci are rare. This is most likely due to an undetermined combination of putative resistancemediating mutations exhibited by clinical isolates. Only studies by Locke et al. 7 analysing laboratory-derived resistant strains have confirmed a correlation for selected mutations. From the mutations described, only the L3 alterations Gly152Asp and Ala157Arg were detected in isolates of the present study.
cfr incorporation into novel plasmid backbones
Six of our isolates additionally carried cfr-expressing plasmids. In most cases cfr was found in combination with other mutations in the 23S rRNA, L3 and/or L4, which, however, do not necessarily result in linezolid resistance as they were also detected in linezolid-susceptible control strains. Linezolid MICs were significantly higher when cfr was detected together with the G2576T mutation. However, our study also included strains lacking cfr and the G2576T mutation, but expressing linezolid MICs of .256 mg/L. Higher MICs are often found in CoNS with a combination of resistance mechanisms and further investigations are needed to understand this complex interaction. 37, 44 The present study describes the occurrence of two different cfr-expressing plasmids in the population of S. epidermidis in German hospitals. The two plasmid categories differed not only in their vector backbone, but also with respect to their mobile genetic elements, putatively responsible for incorporation of the cfr locus. More importantly, both described categories varied in genetic arrangement and composition from previously published cfr plasmids.
The first category of plasmids analysed, C1, showed significant homology in overall vector sequence to S. aureus plasmids pV030-8 and pGO1 (query coverage 75%, identity 96%; accession numbers NC_010279.1 and NC_012547.1, respectively). The latter is considered a prototype for class III staphylococcal plasmids, the nucleotide sequence of which was determined in 2009. 28, 47 These often multidrug resistance plasmids have long been known for mediating their own inter-and intra-species transfer. 28, 47 Accordingly, p12-00322 and homologues encode a conjugation machinery, which is likely to facilitate transfer of the promiscuous vector to bacteria of the same genus or species. In this study, identical plasmids of C1 were detected in strains of different sequence types within the same hospital, thus suggesting a certain degree of transferability and thus plasmid dissemination in hospital environments. We not only verified intra-and interspecies transfer but also demonstrated that plasmid p12-00322 can be received by and propagated in the distantly related Gram-positive E. faecalis, where it also mediates florfenicol resistance. In general, exchange of episomal genetic material between enterococci and staphylococci was shown to occur at frequencies similar to the frequencies reported here, with an efficiency of 10
27
/donor cfu. 48 Plasmid p12-00322 harbours sequences surrounding the cfr locus that are homologous to IS21 -558 of pSCFS6. However, and unlike pSCFS6, the cfr-lsaB locus of p12-00322 is flanked by IS257 transposases rather than IS21 elements. 30 Thus, p12-00322-derived transposons represent novel IS257-cfr elements that add to the manifold mobile cfr-encoding structures. Copies of IS257 are known to frame various resistance loci, such as the cadmium and trimethoprim resistance cassettes of S. aureus and S. epidermidis. 49 -51 But unlike multiresistance vectors, p12-00322 and C1 category plasmids lack the apparent resistance loci for mupirocin, trimethoprim, gentamicin, kanamycin or b-lactam antibiotic resistance. 28, 52 To our current understanding, this is the first report of a broad host-range conjugative and cfr-expressing plasmid in S. epidermidis. Regarding plasmidmediated resistance through expression of the methyltransferase cfr, the appearance of a self-transferable cfr-positive plasmid is worrisome, as a rapid spread of the resistance locus can be expected under selective pressure due to extensive linezolid medication.
In contrast to putative parental plasmids such as pGO1, no additional resistance genes were detected on either of the C1 category vectors. However, and as outlined in the present study, investigation of C2 plasmids revealed the presence of an additional phenicol exporter, fexA (Figure 1b) . Together with the gene for the DNA invertase bin3, an NAD(P)H oxidoreductase and the cfr locus, the entire resistance element resembles that of a Tn558 variant of pSCFS7 from S. aureus (accession number FR675942). 53 In contrast, homologies of the vector backbone were most significant to S. aureus plasmid pSK73. Cfr-resistance plasmid pSCFS7 was detected in a variant of the S. aureus USA300 clone. 53 As the authors did not pursue characterization of the plasmid backbone it remains elusive whether p12-02300 is identical to pSCFS7 and has been exchanged between CoNS and S. aureus populations or whether the mobile element comprising cfr and fexA has been acquired and inserted into a different plasmid backbone, such as pSK73, in an entirely independent manner. Furthermore, Fessler et al. 54 demonstrated transfer of pSCFS7 by the mechanism of conjugation. There is no evidence that p12-02300 encodes a conjugation machinery, contradicting the hypothesis of an identical plasmid sequence. However, co-mobilization of p12-02300 facilitated by helper plasmids of unknown origin cannot be excluded on the basis of current investigations. Besides being prominent in strain USA300, two methicillin-resistant human isolates of S. aureus and S. haemolyticus were reported recently to harbour pSCFS7-like plasmids. 54 To the best of our knowledge, this is the first report of p12-02300 (pSCFS7)-like plasmids in clinical isolates of S. epidermidis. Interestingly, and in contrast to p12-00322-like plasmids, which seem to have been confined to a single hospital until now (hospital C, see above), preliminary PCR-based investigations of cfr-positive S. epidermidis isolates received by our National Reference Centre for Staphylococci and Enterococci verified the distribution of p12-02300-like plasmids throughout Germany (not shown). Thus, spread of the respective vector beyond genus boundaries is likely to occur in a hospital setting and might account for the emergence of S. epidermidis lineages propagating p12-02300 (pSCFS7)-like plasmids.
